第4天至第7天到达囊胚期的人类胚胎的发育命运早在受精阶段就已出现差异
这项回顾性研究利用延时成像技术监测了9450个ICSI周期中第4天(N=70)、第5天(N=6147)、第6天(N=3243)和第7天(N=149)形成的囊胚,比较其形态动力学和临床结局。结果显示,囊胚形成时间越晚,临床结局越差,且发育模式的差异早在原核消失(tPNf)时即已显现。第6天囊胚的着床、临床妊娠、持续妊娠和活产概率显著低于第5天囊胚。
要点
- 囊胚形成时间越晚,着床率、持续妊娠率和活产率进行性降低(P < 0.0001)。
- 第6天囊胚的着床、临床妊娠、持续妊娠和活产概率显著低于第5天囊胚。
- 发育时间差异早在原核消失(tPNf)时即已明显(P < 0.0001)。
核心结论
- 囊胚形成时间延长与较差的临床结局相关,发育模式的紊乱早在受精阶段即已出现。
研究设计与样本
- 回顾性研究,利用延时成像技术监测9450个ICSI周期中第4天(N=70)、第5天(N=6147)、第6天(N=3243)和第7天(N=149)形成的囊胚。
- 卵母细胞 Retrieval 在2020年1月至2021年4月间于克罗米芬枸橼酸盐为基础的温和卵巢刺激后进行。
主要发现
- 从19846个显微注射卵母细胞中获得17144个受精卵(86.4%),总囊胚形成率为56.0%。
- 第4、5、6、7天囊胚形成率分别为0.7%、64.0%、33.8%、1.6%。
- 第4-7天组平均扩张囊胚发育时间分别为98.4 ± 0.4、112.4 ± 0.1、131.6 ± 0.1、151.2 ± 0.5小时。
- 原核消失(tPNf)时间在第4-7天组分别为20.6 ± 0.3、22.5 ± 0.0、24.0 ± 0.0、25.5 ± 0.3小时(P < 0.0001)。
- 第6天囊胚的着床、临床妊娠、持续妊娠和活产概率显著低于第5天囊胚(控制女性年龄、男性年龄、既往胚胎移植周期数、ICM和TE形态学分级及黄体酮补充后)。
关键数值与推荐
- 内细胞团(ICM)和滋养外胚层(TE)形态学A级囊胚率与囊胚发育天数呈负相关(P < 0.0001)。
- 第一次或第二/第三次分裂周期中发生的卵裂异常(三/多极有丝分裂或快速卵裂)率与囊胚发育时间延长呈正相关。
- 着床率、持续妊娠率和活产率随囊胚发育时间延长进行性降低(P < 0.0001),即使按母亲年龄分层后仍如此。
临床怎么用
- 原文未据此给出推荐。
局限性
- 研究受限于其回顾性设计。
- 数据来自单中心,需要独立验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What clinical and laboratory differences emerge from parallel direct comparison of embryos reaching the blastocyst stage between Days 4, 5, 6, and 7 (Days 4-7)? SUMMARY ANSWER: Increasing times to blastocyst formation are associated with a worse clinical outcome and perturbations in developmental patterns appear as early as the fertilization stage. WHAT IS KNOWN ALREADY: Previous evidence indicates that later times to blastocyst development are associated with a worse clinical outcome. However, the vast majority of these data concern Day 5 and Day 6 blastocysts, while Day 4 and Day 7 blastocysts remain less thoroughly investigated. In addition, studies comparing in parallel the developmental patterns and trajectories of Day 4-7 blastocysts are lacking. This leaves unanswered the question of when and how differences among such embryos emerge. Acquisition of such knowledge would significantly contribute to understanding the relative impact of intrinsic and extrinsic causes of embryo developmental kinetics and competence. STUDY DESIGN, SIZE, DURATION: This retrospective study involved time-lapse technology (TLT) monitoring of Day 4 (N = 70), Day 5 (N = 6147), Day 6 (N = 3243), and Day 7 (N = 149) blastocysts generated in 9450 ICSI cycles. Oocyte retrievals were carried out after clomiphene citrate-based minimal ovarian stimulation, between January 2020 and April 2021. PARTICIPANTS/MATERIALS, SETTING, METHODS: Couples included in the study presented with different diagnoses, mainly male factor and unexplained infertility. Cases involving cryopreserved gametes or surgically retrieved sperm were excluded. Microinjected oocytes were assessed by a combined TLT-culture system. Day 4-7 blastocyst groups were compared in terms of morphokinetics (pronuclear dynamics, cleavage patterns and timings, and embryo quality) and clinical outcome. Clinically usable blastocysts were cryopreserved and transferred in single vitrified-warmed blastocyst transfers (SVBT). MAIN RESULTS AND THE ROLE OF CHANCE: From 19 846 microinjected oocytes, 17 144 zygotes (86.4%) were obtained. Overall, the blastocyst development rate was 56.0%. Rates of blastocysts formation on Days 4, 5, 6, and 7 were 0.7%, 64.0%, 33.8%, and 1.6%, respectively. The average expanded blastocyst development times were 98.4 ± 0.4, 112.4 ± 0.1, 131.6 ± 0.1, and 151.2 ± 0.5 h in the Day 4-7 groups, respectively. Female age was positively associated with longer times to blastocyst development. Rates of both inner cell mass (ICM) and trophectoderm (TE) morphological grade A blastocysts were negatively associated with the day of blastocyst development (P < 0.0001). The differences in development times and intervals increased progressively until blastocyst expansion (P < 0.0001 for all development times). Strikingly, such differences were already markedly evident as early as the time of pronuclear fading (tPNf) (20.6 ± 0.3, 22.5 ± 0.0, 24.0 ± 0.0, 25.5 ± 0.3; Days 4-7, respectively; P < 0.0001). Rates of cleavage anomalies (tri-/multi-chotomous mitosis or rapid cleavage) occurring at the first or second/third division cycles were also positively associated with longer times to blastocyst development. Implantation, ongoing pregnancy, and live birth rates were progressively reduced with increasing blastocyst development times (P < 0.0001), even after stratification for maternal age. When controlled for female age, male age, number of previous embryo transfer cycles, morphological grade of the ICM and TE, and progesterone supplementation, the probabilities of implantation, clinical, and ongoing pregnancy and live birth were significantly decreased in Day 6 blastocysts in comparison to Day 5 blastocysts. Follow-up data on birth length, weight, and malformations were comparable among the four blastocyst groups. LIMITATIONS, REASONS FOR CAUTION: The study is limited by its retrospective design. Having been obtained from a single centre, the data require independent validation. WIDER IMPLICATIONS OF THE FINDINGS: This study extends previous data on the relation between time of blastocyst formation and clinical outcome. It also indicates that differences in developmental times and patterns of Day 4-7 blastocysts occur as early as the fertilization stage, possibly dictated by intrinsic gamete-derived factors. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by the participating institutions. The authors have no conflict of interest to declare. TRIAL REGISTRATION NUMBER: N/A.
引用
- Coticchio G, Ezoe K, Lagalla C, et al. The destinies of human embryos reaching blastocyst stage between Day 4 and Day 7 diverge as early as fertilization. Hum Reprod. 2023. PMID: 37381073. doi:10.1093/humrep/dead136
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。